Bioavailability/Bioequivalence on Biopharmaceutical Products
The Bioavailability Bioequivalence Research Center aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. It plays a key role in the drug development period for both new drug products and their generic equivalents. These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners can be discussed
- Factors affecting bae
- BABE studies
- Assesssment of bioeqivalence
- In vivo/In vitro studies
- Latest Updates In BA/BE
Related Conference of Bioavailability/Bioequivalence on Biopharmaceutical Products
Bioavailability/Bioequivalence on Biopharmaceutical Products Conference Speakers
Recommended Sessions
- Bioavailability/Bioequivalence on Biopharmaceutical Products
- Biologics and Biosimilars
- Biopharmaceutical Companies & Market Analysis
- Biopharmaceutical Pharmacovigilance
- Biopharmaceuticals
- Biopharmaceutics: Drug Discovery and Development
- Biotechnological Products
- Cellular and Gene Therapy
- clinical Trials on Biopharmaceutical Products
- Drug Delivery from Plant Extracts
- Drug Delivery System of Biopharmaceutical Products
- Drug Disposition & Pharmacokinetics
- Drug Dissolution of Biopharmaceutical Products
- Entrepreneurs Investment Meet
- Pharmaceutical Regulatory Affairs And IPR
- Pharmacovigilance
- Therapeutic Biological Products
Related Journals
Are you interested in
- Bioequivalence Assessment - Asian Biosimilars 2019 (Australia)
- Biologics and Biosimilars - Asian Biosimilars 2019 (Australia)
- Biopharmaceuticals - Asian Biosimilars 2019 (Australia)
- Biosimilars & Biologics: Clinical Studies & Trials - Asian Biosimilars 2019 (Australia)
- Biosimilars & Biologics: Current Challenges - Asian Biosimilars 2019 (Australia)
- Biosimilars Analytical Strategies - Asian Biosimilars 2019 (Australia)
- Biosimilars: Pharmacovigilance and Safety - Asian Biosimilars 2019 (Australia)
- Challenges in Biosimilars Pharmacovigilance - Asian Biosimilars 2019 (Australia)
- Clinical Development Of Biosimilars - Asian Biosimilars 2019 (Australia)
- Globalization of Biosimilars - Asian Biosimilars 2019 (Australia)
- Innovation and Technology for Biosimilar Development - Asian Biosimilars 2019 (Australia)
- Pharmaceutical Regulatory Affairs And IPR - Asian Biosimilars 2019 (Australia)
- Regulatory Approach for Biosimilars - Asian Biosimilars 2019 (Australia)
- Therapeutic Biological Products - Asian Biosimilars 2019 (Australia)